Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Multisite Study of the Treatment of Chronic Hepatitis C Virus Infection Genotype 1 in a Real World Large Health Maintenance Organization: An Evaluation of Real World Sustained Virological Response and Patient Reported Outcomes

NCT02461745 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT02461745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02461745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Multisite Study of the Treatment of Chronic Hepatitis C Virus Infection Genotype 1 in a Real World Large Health Maintenance Organization: An Evaluation of Real World Sustained Virological Response and Patient Reported Outcomes
Lead sponsor
Kaiser Permanente
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2015
Completion date
May 31, 2017
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic